InsidersTradesSigma
Follow the Nasus Pharma Ltd share price and the full management transaction log of the company, a publicly traded company based in United States. Shares are quoted on US US, under the authority of SEC (Form 4). Market capitalisation: €35.2m. The latest transaction was disclosed on 22 April 2026 (Acquisition). Among the most active insiders: Teleman Dan Benjamin. All data is free.
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
2 of 2 declarations
Nasus Pharma Ltd is a company focused on developing innovative treatments for respiratory diseases. It is listed on the XNAS market.